GeoVax Labs Archives

GeoVax Secures Patent for Groundbreaking Malaria Vaccine Platform – ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. June 25, 2025 563Views 0Likes

In a move that both underlines scientific ingenuity and bolsters global health ambitions, GeoVax Labs, Inc. (GOVX) has announced the issuance of U.S. Patent No. 12,329,808, a milestone that covers a novel vaccine construct designed to prevent malaria infection. This patent, granted…

GeoVax Applauds FDA’s Green Light for Keytruda: A New Chapter in Head and Neck Cancer—and a Wink at Gedeptin’s Future – ( $GOVX $MRK $XBI )

by John F. Heerdink, Jr. June 24, 2025 470Views 0Likes

In the ever-evolving world of oncology, every so often a regulatory decision comes along that feels less like a footnote and more like a new chapter. The U.S. Food and Drug Administration’s (FDA) recent approval of Merck’s (MRK) Keytruda® (pembrolizumab) for resectable,…

GeoVax Labs: A Shot in the Arm for Global Health, with a European Twist – ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. June 18, 2025 476Views 0Likes

In a world where vaccine innovation can sometimes feel like a slow-motion sprint, GeoVax Labs, Inc. (NASDAQ: GOVX) has just received a welcome boost—this time, courtesy of European regulators. The company, known for its nimble approach to tackling some of the world’s…

GeoVax Labs

GeoVax Secures Patent for Groundbreaking Malaria Vaccine Platform – ( $GOVX $IBB $XBI )

GeoVax Applauds FDA’s Green Light for Keytruda: A New Chapter in Head and Neck Cancer—and a Wink at Gedeptin’s Future – ( $GOVX $MRK $XBI )

GeoVax Labs: A Shot in the Arm for Global Health, with a European Twist – ( $GOVX $IBB $XBI )

Your Guide To Staying Informed In The Markets